Prevention
B155 – B165
- B155: A focus group study in Ireland of women’s views, attitudes and knowledge of cervical screening and Human Papillomavirus (HPV)
- B156: Promoting “care in the sun” activities for the early years – Skin Cancer Prevention Project
- B157: Outcome of the prevalence screen in the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- B158: Impact of anastrozole on cognition: results from the IBIS II (prevention) cognitive subprotocol
- B159: Direct mechanisms of UVA- and solar radiation-induced protein, lipid and DNA oxidation relevant to human skin photodamage
- B160: Consuming broccoli interacts with GSTM1 genotype to perturb oncogenic signalling pathways in the human prostate
- B161: Phase I repeat-dose clinical study of safety, pharmacokinetics and pharmacodynamics of the putative cancer chemopreventive agent resveratrol
- B162: Assessing oxidative DNA damage in bladder cancer cells using the modified alkaline comet assay
- B163: The impact of chemoprevention on treatment regimes for non muscle invasive bladder cancer
- B164: HPV testing in combination with liquid-based cytology in primary cervical screening: a randomised trial
- B165: Prevention of Endometrial Tumours, a randomised control trial of the effect of the Mirena Intrauterine System (IUS) with surveillance, versus surveillance alone, on the development of atypical endometrial hyperplasia (AEH) and carcinoma (EC) in women with Lynch Syndrome aged 35-65y
